Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ADCT Appoints Senior VP of R&D

Published: Thursday, July 19, 2012
Last Updated: Thursday, July 19, 2012
Bookmark and Share
Appointment of former Genmab vice president Dr Patrick van Berkel as senior vice president.

ADC Therapeutics (ADCT) has announced the appointment of former Genmab Vice President Dr Patrick van Berkel as Senior Vice President, Research & Development.

Dr van Berkel has more than twenty years’ experience in the biotech industry, and in particular in developing antibody based therapeutics.

He served with Genmab for more than nine years in different divisions; his most recent position was as Vice President of Chemistry, Manufacturing and Control (CMC), Research & Development.

Previously, he held senior positions, including Director of Technology for the Antibody Technology division, before moving across to CMC in 2008.

Prior to Genmab, Dr van Berkel worked for both Crucell and Pharming Technologies. He is an author on at least nine antibody patents and has published over thirty peer-reviewed scientific papers during his career in the industry.

Michael Forer, CEO of ADCT and a Partner in Celtic Therapeutics, the private equity firm which is its majority shareholder, said: “Patrick is highly experienced in developing ADC therapies and will be a great asset to ADCT as we move forward in developing our pipeline. He has worked in the biologics area for two decades, including successfully taking concept ADCs towards IND. We are very pleased he is joining our team.”

On his appointment, Dr van Berkel said: “The coming decade will see an explosion in ADC therapies in development and coming to market, given their potential to deliver more targeted antibody therapies with fewer side effects. It is an exciting time to join ADCT. I believe ADCT has the potential to become a major player in this area and I look forward to the opportunity to help drive the business forward.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
New Skin Cancer Drugs with Surprising Powers
Inserm team synthesizes and developed new drugs for melanoma.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!